Costs and Expenses of ABEONA THERAPEUTICS INC. from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
ABEONA THERAPEUTICS INC. quarterly and annual Costs and Expenses in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • ABEONA THERAPEUTICS INC. Costs and Expenses for the quarter ending 30 Sep 2025 was $24,018,000, a 57% increase year-over-year.
  • ABEONA THERAPEUTICS INC. annual Costs and Expenses for 2018 was $61,164,000, a 113% increase from 2017.
  • ABEONA THERAPEUTICS INC. annual Costs and Expenses for 2017 was $28,673,000, a 16% increase from 2016.
  • ABEONA THERAPEUTICS INC. annual Costs and Expenses for 2016 was $24,770,000, a 26% increase from 2015.
Source SEC data
View on sec.gov
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Change (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Change (%)

ABEONA THERAPEUTICS INC. Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $24,018,000 +$8,673,000 +57% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $15,345,000 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2019 $80,147,000 $23,976,000 +$11,143,000 +87% 01 Apr 2019 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $69,004,000 $19,054,000 +$7,840,000 +70% 01 Jan 2019 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $61,164,000 $18,492,000 +$9,527,000 +106% 01 Oct 2018 31 Dec 2018 10-K 18 Mar 2019 2018 FY
Q3 2018 $51,637,000 $18,625,000 +$13,044,000 +234% 01 Jul 2018 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 $38,593,000 $12,833,000 +$4,176,000 +48% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 $34,417,000 $11,214,000 +$5,744,000 +105% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q4 2017 $28,673,000 $8,965,000 +$2,877,000 +47% 01 Oct 2017 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 $25,796,000 $5,581,000 +$223,000 +4.2% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2018 Q3
Q2 2017 $25,573,000 $8,657,000 +$1,728,000 +25% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $23,845,000 $5,470,000 -$925,000 -14% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $24,770,000 $6,088,000 -$380,000 -5.9% 01 Oct 2016 31 Dec 2016 10-K 18 Mar 2019 2018 FY
Q3 2016 $25,150,000 $5,358,000 -$1,091,000 -17% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $26,241,000 $6,929,000 +$2,520,000 +57% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2
Q1 2016 $23,721,000 $6,395,000 +$4,135,000 +183% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $19,586,000 $6,468,000 +$5,767,000 +823% 01 Oct 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q3 2015 $13,819,000 $6,449,000 +$5,580,000 +642% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 $8,239,000 $4,409,000 +$3,459,000 +364% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016 2016 Q2
Q1 2015 $4,780,000 $2,260,000 +$724,000 +47% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
Q4 2014 $4,056,000 $701,000 -$145,000 -17% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q3 2014 $4,201,000 $869,000 -$16,000 -1.8% 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015 2015 Q3
Q2 2014 $4,217,000 $950,000 -$1,438,000 -60% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2015 Q2
Q1 2014 $5,655,000 $1,536,000 -$191,000 -11% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q1
Q4 2013 $5,846,000 $846,000 -$1,379,000 -62% 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q3 2013 $7,225,000 $885,000 -$942,000 -52% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2014 Q3
Q2 2013 $8,167,000 $2,388,000 +$246,000 +11% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2014 Q2
Q1 2013 $7,921,000 $1,727,000 -$799,000 -32% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q4 2012 $8,720,000 $2,225,000 +$37,000 +1.7% 01 Oct 2012 31 Dec 2012 10-K 26 Mar 2014 2013 FY
Q3 2012 $8,683,000 $1,827,000 -$998,000 -35% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013 2013 Q3
Q2 2012 $9,681,000 $2,142,000 -$261,000 -11% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013 2013 Q2
Q1 2012 $9,942,000 $2,526,000 +$227,000 +9.9% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1
Q4 2011 $9,715,000 $2,188,000 01 Oct 2011 31 Dec 2011 10-K 20 Mar 2013 2012 FY
Q3 2011 $2,825,000 +$402,000 +17% 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012 2012 Q3
Q2 2011 $2,403,000 +$358,000 +18% 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012 2012 Q2
Q1 2011 $2,299,000 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012 2012 Q1
Q3 2010 $2,423,000 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011 2011 Q3
Q2 2010 $2,045,000 02 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011 2011 Q2

ABEONA THERAPEUTICS INC. Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2018 $61,164,000 +$32,491,000 +113% 01 Jan 2018 31 Dec 2018 10-K 18 Mar 2019 2018 FY
2017 $28,673,000 +$3,903,000 +16% 01 Jan 2017 31 Dec 2017 10-K 18 Mar 2019 2018 FY
2016 $24,770,000 +$5,184,000 +26% 01 Jan 2016 31 Dec 2016 10-K 18 Mar 2019 2018 FY
2015 $19,586,000 +$15,530,000 +383% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
2014 $4,056,000 -$1,790,000 -31% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
2013 $5,846,000 -$2,874,000 -33% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
2012 $8,720,000 -$995,000 -10% 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2014 2013 FY
2011 $9,715,000 +$1,477,000 +18% 01 Jan 2011 31 Dec 2011 10-K 20 Mar 2013 2012 FY
2010 $8,238,000 01 Jan 2010 31 Dec 2010 10-K 23 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.